ABVC BioPharma, Inc. Banking Regulation, Total Capital, Actual
ABVC BioPharma, Inc. (ABVC) had Banking Regulation, Total Capital, Actual of $3.64 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Banking and Thrift
us-gaap:Capital · last filed 2023-08-14
- 2023-06-30: Banking Regulation, Total Capital, Actual $3.64M.
- 2023-03-31: Banking Regulation, Total Capital, Actual $1.59M.
- 2022-12-31: Banking Regulation, Total Capital, Actual $2.83M.
| Period end | Banking Regulation, Total Capital, Actual |
|---|---|
| 2023-06-30 | $3.64M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.59M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.83M 10-K · filed 2023-03-31 |